Measures of anxiety, sensorimotor function, and memory in male and female mGluR4 -/- mice

Behavioural Brain Research

Volumn 229, Issue 1, 2012, Pages 21-28

  Davis, Matthew J ^a   Haley, Tammie ^b   Duvoisin, Robert M ^b   Raber, Jacob ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anxiety; Group III mGluR; Learning; Memory; MGluR4

Indexed keywords

METABOTROPIC RECEPTOR 4;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; FEAR; FEMALE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MENTAL CAPACITY; MENTAL PERFORMANCE; MOUSE; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; ROTAROD TEST; SENSORIMOTOR FUNCTION; SEX DIFFERENCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANILIDES; ANIMALS; ANXIETY; BODY WEIGHT; CONDITIONING (PSYCHOLOGY); CUES; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; FEAR; FEMALE; GAIT DISORDERS, NEUROLOGIC; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, METABOTROPIC GLUTAMATE; ROTAROD PERFORMANCE TEST; SEX CHARACTERISTICS;

EID: 84855890692     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.12.037     Document Type: Article

References (34)

1. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995, 34:1-26.
2. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997, 37:205-237.
3. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 2000, 75:889-907.
4. Swanson C., Bures M., Johnson M., Linden A.-M., Monn J., Schoepp D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 2005, 4:131-144.
5. Linden A.M., Johnson B.G., Peters S.C., Shannon H.E., Tian M., Wang Y., et al. Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 2002, 43:251-259.
6. Duvoisin R., Zhang C., Pfankuch T., O'Connor H., Gayet-Primo J., Quraishi S., et al. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur J Neurosci 2005, 22:1-13.
7. Duvoisin R., Villasana L., Pfankuch T., Raber J. Sex-dependent cognitive phenotype of mice lacking mGluR8. Behav Brain Res 2010, 209:21-26.
8. Duvoisin R., Villasana L., Davis M., Winder D.G., Raber J. Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges. Behav Brain Res 2011, 221:50-54.
9. Duvoisin R., Pfankuch T., Wilson J., Grabell J., Chhajlani V., Brown D., et al. Acute pharmacological modulation of mGluR8 reduces measures of anxiety. Behav Brain Res 2010, 212:168-173.
10. Pekhletski R., Gerlai R., Overstreet L.S., Huang X.P., Agopyan N., Slater N.T., et al. Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J Neurosci 1996, 16:6364-6373.
11. Bradley S.R., Standaert D.G., Levey A.I., Conn P.J. Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies. Ann N Y Acad Sci 1999, 868:531-534.
12. Corti C., Aldegheri L., Somogyi P., Ferraguti F. Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 2002, 110:403-420.
13. Benice T., Rizk A., Pfankuch T., Kohama S., Raber J. Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006, 137:413-423.
14. Morris R.J. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
15. Anagnostaras S., Wood S., Shuman T., Cai D., Leduc A., Zurn K., et al. Automated assessment of Pavlovian conditioned freezing and shock reactivity in mice using the video freeze system. Front Behav Neurosci 2010, 4:1-11.
16. Maren S. Neurobiology of Pavlovian fear conditioning. Ann Rev Neurosci 2001, 24:897-931.
17. Debiec J., Ledoux J. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience 2004, 129:262-272.
18. Fanselow M. Neural organization of the defensive behavior system responsible for fear. Psychonom Bull Rev 1994, 1:429-438.
19. Jones B., Roberts D. The quantitative measurement of motor in co-ordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 1968, 20:302-304.
20. Hopkins C., Lindsley C., Niswender C. mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease. Future Med Chem 2009, 1:501-513.
21. Strickland D., Bertoni J. Parkinson's prevalence estimated by a state registry. Mov Disord 2003, 19:318-323.
22. Van Den Eeden S., Tanner C., Bernstein A., Fross R., Leimpeter A., Bloch D., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003, 157:1015-1022.
23. Valenti O., Mannaioni G., Seabrook G., Conn P., Marino M. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons. J Pharmacol Exp Ther 2005, 313:1296-1304.
24. Marino M., Hess J., Liverton N. Targeting the methabotropic glutamate receptor mGluE4 for the treatment of the central nervous system. Curr Top Med Chem 2005, 5:885-895.
25. Maj M., Bruno V., Dragic Z., Yamamoto R., Battaglia G., Inderbitzin W., et al. (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 2003, 45:895-906.
26. Landfield P.W., Baskin R.K., Pitler T.A. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science 1981, 214:581-584.
27. Raber J., Akana S.F., Bhatnager S., Dallman M.F., Wong D., Mucke L. Hypothalamic-pituitary-adrenal dysfunction in ApoE-/- mice: possible role in behavioral and metabolic alterations. J Neurosci 2000, 20:2064-2071.
28. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994, 17:525-530.
29. Sullivan P., Mace B., Maeda N., Schmechel D. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 2004, 124:725-733.
30. Ramaswamy G., Xu Q., Huang Y., Weisgraber K. Effect of domain interaction on apolipoprotein E levels in mouse brain. J Neurosci 2005, 25:10658-10663.
31. Siegel J.A., Haley G.E., Raber J. Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiology of Aging 2012, 33:345-358.
32. Thomsen C., Hampson D. Contribution of metabotropic glutamate receptor mGluR4 to L-2-[3H]amino-4=phosphonobutyrate binding in mouse brain. J Neurochem 1999, 72:835-840.
33. Boulware M., Weick J., Beckund B., Kuo S., Groth R., Mermelstein P. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 2005, 25:5066-5078.
34. Fendt M., Schmid S., Thakker D., Jacobson L., Yamamoto R., Mitsukawa K., et al. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatr 2008, 13:970-979.